Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 3/20 | 0.58 |
| ▸ | CA1 | P00915 | 3/20 | 0.58 |
| ▸ | CA9 | Q16790 | 3/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.56 |
| ▸ | RAB9A | P51151 | 6/20 | 0.56 |
| ▸ | HPGD | P15428 | 5/20 | 0.56 |
| ▸ | NPC1 | O15118 | 5/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.55 |
| ▸ | GAA | P10253 | 2/20 | 0.55 |
| ▸ | GLA | P06280 | 1/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.54 |
| ▸ | CASP3 | P42574 | 1/20 | 0.53 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.53 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.53 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5664318 | 1.00 | CA12 (0.58) | CA12CA1CA9KDM4EALDH1A1 | |
| SCHEMBL29543976 | 1.00 | CA12 (0.58) | CA12CA1CA9KDM4EALDH1A1 | |
| SCHEMBL7203173 | 1.00 | CA12 (0.58) | CA12CA1CA9KDM4EALDH1A1 | |
| Acetic Acid SCHEMBL29576439 | 0.97 | CA12 (0.58) | CA12CA1CA9KDM4EALDH1A1 | |
| Hydrochloric Acid SCHEMBL29398934 | 0.96 | CA12 (0.58) | CA12CA1CA9KDM4EALDH1A1 | |
| Hydrochloric Acid SCHEMBL29787847 | 0.96 | CA12 (0.58) | CA12CA1CA9KDM4EALDH1A1 | |
| SCHEMBL7205674 | 0.92 | CA12 (0.52) | CA12CA1CA9KDM4EALDH1A1 | |
| SCHEMBL7205667 | 0.92 | CA12 (0.52) | CA12CA1CA9KDM4EALDH1A1 | |
| SCHEMBL6918937 | 0.92 | CA12 (0.52) | CA12CA1CA9KDM4EALDH1A1 | |
| SCHEMBL29543708 | 0.92 | CA12 (0.52) | CA12CA1CA9KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116510024-A | Composition, preparation method and application thereof | 上海复东生物医药有限责任公司 | 2023-08-01 | — | — | CN | claimed |
| CN-119264047-A | Quinoline derivative histone deacetylase inhibitor and preparation method and application thereof | 山东大学 | 2025-01-07 | — | — | CN | disclosed |
| WO-2024175450-A1 | SUBSTITUTED S-ALANINATE DERIVATIVES | BAYER AKTIENGESELLSCHAFT (DE) | 2024-08-29 | — | — | WO | disclosed |
| EP-4396183-A1 | SUBSTITUTED S-ALANINATE DERIVATIVES | Bayer Aktiengesellschaft (DE) | 2024-07-10 | — | — | EP | disclosed |
| EP-4093730-B1 | HDAC DEGRADER | UNIV LEICESTER (GB) | 2024-05-08 | — | — | EP | disclosed |
| CN-110167955-B | Bacterial inhibitors | 梅哈里医学院 | 2024-04-02 | — | — | CN | disclosed |
| CN-116510024-A | Composition, preparation method and application thereof | 上海复东生物医药有限责任公司 | 2023-08-01 | — | — | CN | disclosed |
| CN-113717965-B | Streptomyces trypsin specific transformation method and application thereof | 江南大学 | 2023-07-18 | — | — | CN | disclosed |
| US-20230120211-A1 | HDAC Degrader | UNIVERSITY OF LEICESTER (GB) | 2023-04-20 | — | — | US | disclosed |
| WO-2023031083-A1 | SUBSTITUTED S-ALANINATE DERIVATIVES | BAYER AKTIENGESELLSCHAFT (DE) | 2023-03-09 | — | — | WO | disclosed |
| EP-4093730-A1 | HDAC DEGRADER | University of Leicester (GB) | 2022-11-30 | — | — | EP | disclosed |
| US-11504414-B2 | Bacterial inhibitors | MEHARRY MEDICAL COLLEGE | 2022-11-22 | — | — | US | disclosed |
| WO-2022178128-A1 | SELECTIVE NEUTRAL PH INHIBITOR OF CATHEPSIN B | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2022-08-25 | — | — | WO | disclosed |
| US-20220151962-A1 | NOVEL INHIBITORS OF HISTONE DEACETYLASE 10 | DEUTSCHES KREBSFORSCHUNGSZENTRUM (DE) | 2022-05-19 | — | — | US | disclosed |
| EP-3941900-A1 | NOVEL INHIBITORS OF HISTONE DEACETYLASE 10 | Deutsches Krebsforschungszentrum (DE) | 2022-01-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230120211-A1 | HDAC Degrader | HDAC1, HDAC11, HDAC3 | CA12 1918/4885CA1 2103/4885CA9 1107/4885 |
| US-20220151962-A1 | NOVEL INHIBITORS OF HISTONE DEACETYLASE 10 | HDAC10, HDAC1, HDAC11 | CA12 1669/4885CA1 490/4885CA9 1600/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.